Skip to content

Solventum SOLV Additional Paid-In Capital

Additional Paid-In Capital at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$556M
Align Technology logo
Align TechnologyALGN
$1.53B+10.4%
Globus Medical logo
Globus MedicalGMED
$3.21B+5.0%
Baxter International logo
Baxter InternationalBAX
$6.21B-1.5%
Fortive logo
FortiveFTV
$4.23B+3.8%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$6.73B+2.1%

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's additional paid-in capital?
Solventum (SOLV) reported additional paid-in capital of $3.9B in Q1 2026.
How has Solventum's additional paid-in capital changed year-over-year?
Solventum's additional paid-in capital increased by 3.0% year-over-year, from $3.78B to $3.9B.
What does additional paid-in capital mean?
Capital contributed by shareholders above the nominal par value of shares.
How do you interpret additional paid-in capital?
An increase indicates successful equity financing or the issuance of stock-based compensation, signaling potential dilution for existing shareholders.
How does additional paid-in capital compare across companies?
Common in public companies; reflects historical equity issuance activity and compensation practices.